Elecsys AFP
Kit, Test,Alpha-Fetoprotein For Testicular Cancer. 510(k) K220176, from Roche Diagnostics (Indianapolis, IN). Product code LOJ, class 2.
As of Nov 20, 2026, K220176 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Sep 15, 2022 after 237 days, with no recalls tied to it in FDA's recall database.
- Review time: 237 days
- Recalls: 0
Immunoassay for the in vitro quantitative determination of α1-fetoprotein in human serum and plasma to aid in the management of patients with non-seminomatous germ cell tumors. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers.
- Elecsys AfpK981282 · Roche Diagnostics GmbH · May 1, 1998
- Vitros AfpK213626 · Ortho Clinical Diagnostics · Jun 15, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 21, 2022
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files